This document discusses anti-psychotic medications. It describes how anti-psychotics work by inhibiting dopamine to treat psychosis symptoms. The document categorizes anti-psychotics as first-generation or typical, and second-generation or atypical. Typical anti-psychotics are further divided into basal and incisive, while atypical anti-psychotics have multi-receptor targets and include multi-acting receptor targeted antagonists, dopamine-serotonin antagonists, dopamine D2-D3 antagonists, and a dopamine partial agonist. The document notes the pharmacokinetics, side effects, and therapeutic strategies for using anti-psychotics.